2023 Oncology Update Symposium

Tysons Corner, VA US
June 24, 2023

Overview

The GW Cancer Center is pleased to provide this extensive update of the latest diagnostic and therapeutic advances in the field of Oncology. A panel of experts will deliver the most relevant, cutting-edge science in Oncology today and offer practical tools to help practitioners incorporate these advances into their daily clinical practice.
 
Course Highlights
  • There are several unique features that set this course apart from the others:
  • Expert Faculty- Our faculty, unmatched in experience and expertise presenting the latest scientific findings in Oncology
  • All content can be conveniently accessed from any computer, mobile device, or smartphone
  • Access to the Course Electronic Syllabus and Slide Handouts

Target Audience

This activity is intended to meet the educational needs of the healthcare team including but not limited to:
  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

Learning Objectives

At the conclusion of the activity, participants will be able to:

  • Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors.
  • Identify the side effects, indications, and contraindications of therapies used to diagnose and treat cancers.
  • Explain effective strategies for managing side effects associated with cancer treatment.
  • Review presented abstracts and discuss their application in clinical practice.
Course summary
Available credit: 
  • 7.00 ABIM MOC 2
  • 7.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 7.00 Completion
Course opens: 
11/16/2022
Course expires: 
12/31/2024
Event starts: 
06/24/2023 - 7:00am EDT
Event ends: 
06/24/2023 - 5:00pm EDT
Cost:
$100.00
Add to calendar: 
Rating: 
0

Program

Program Agenda

 

Saturday, June 24, 2023- Oncology Update Symposium

TIME

TOPIC

PRESENTER

07:00 AM – 08:00 AM

Breakfast | Visit Exhibit Hall

Exhibitors | Attendees

08:00 AM – 08:05 AM

Welcome | Housekeeping Notes

Robert S. Siegel, MD
Professor of Medicine, Associate GW Cancer Center Director of Education and Training, The George Washington University, GW Cancer Center

08:05 AM – 09:05 AM

Updates in Breast Cancer

Pavani Chalasani, MD
Associate Professor of Medicine, Division Director Hematology/Oncology, The George Washington University

09:05 AM – 10:00 AM

Updates in Lung Cancer

Benjamin Levy, MD
Associate Professor,
The Johns Hopkins School of Medicine

10:00 AM – 10:20 AM

Break | Visit Exhibit Hall

Exhibitors | All Attendees

10:20 AM – 11:20 AM

Updates on Neuro-Oncology

Matthias Holdhoff, MD, PhD
Co-Director, Brain Cancer Disease Group, Associate Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

11:20 AM – 12:15 PM

Updates in Genitourinary Cancers

Jeanny B. Aragon-Ching, MD, FACP
Clinical Program Director of Genitourinary Cancers,
Inova Schar Cancer Institute

12:15 PM – 01:15 PM

Lunch | Visit Exhibit Hall

Exhibitors | Attendees

12:15 PM – 01:15 PM

Lunch Product Forum

Sponsored by Genmab

01:15 PM – 02:00 PM

New Drugs and Therapies for Cancer Treatments

Edward Chu, MD, MMS
Director, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine

02:00 PM – 02:45 PM

Update on Hematologic Malignancies

Imad A. Tabbara, MD
Chief, Division of Hematology/ Oncology of DeCesaris Cancer Institute, Clinical Professor of Medicine, The George Washington University

02:45 PM – 03:30 PM

Malignancies Affecting the Liver

Nilofer Azad, MD
Professor of Oncology, Co-Leader, Cancer Genetics and Epigenetics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

03:30 PM – 04:15 PM

Cancers of the Esophagus, Stomach and Colorectal Carcinoma

David Ilson, MD, PhD
Attending Physician
Memorial Sloan Kettering Cancer Center

04:15 PM – 04:20 PM

Closing Remarks | Adjournment

Robert S. Siegel, MD
Professor of Medicine, Associate GW Cancer Center Director of Education and Training, The George Washington University, GW Cancer Center

Venue

Tysons Corner Marriott
8028 Leesburg Pike
Tysons Corner, VA 22182
United States
+1 (800) 228-9290
Tysons Corner Marriott website

Tysons Corner Marriott

Enoy an inspired stay at our redesigned Tysons Corner hotel. Located 20 minutes form Washington Dulles International Airport and Ronald Reagan Washington National Airport, our hotel will make your commute easy. Our hotel offers a relaxed environment and restaurant, a menu of delicious favorites. 

Room Reservations

  • Group Rate: US $131.00 per night, plus 13% room tax 
  • Cancellations are permitted 72 hours prior to arrival to avoid cancellation penalty of one night’s room and tax fee.
  • Reservations can be booked directly through the hotel beginning on Monday, April 10, 2023, by calling +1-800-228-9290 or +1-703-734-3200 and refer to group name (The George Washington University Oncology Update Program) or book your guestroom reservations by using the group discount booking link- 2023 Oncology Update Symposium Room Reservations link- BOOK TODAY
  • All reservations should be received by the Hotel no later than Wednesday, May 24, 2023

Check-in | Check Out

  • Check-in:   4:00 PM
  • Checkout: 12:00 PM

Logistical Inquiries

If you have any additional questions about your hotel booking or other logistical arrangements, please email your inquiries to HEMONCBP_Inquiries@finaww.com. 

Faculty

Faculty & Disclosure

Planning Committee
 
Robert S. Siegel, MD (Activity Director)
Professor of Medicine
Associate GW Cancer Center Director of Education and Training
The George Washington University, GW Cancer Center
 
Faculty
 
Jeanny B. Aragon-Ching, MD, FACP
Clinical Program Director of Genitourinary Cancers
Inova Schar Cancer Institute
Associate Professor of Medical Education
The University of Virginia
 
Nilofer Azad, MD
Professor of Oncology
The Johns Hopkins University
 
Pavani Chalasani, MD
Associate Professor of Medicine, Division Director Hematology/Oncology
The George Washington University
 
Edward Chu, MD
Director and Vice-President
Montefiore Einstein Cancer Center
Albert Einstein College of Medicine
 
Matthias Holdhoff, MD, PhD
Associate Professor of Oncology, Neurology and Neurosurgery
Co-Director, Brain Cancer Disease Group
Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins University
 
David H. Ilson, MD PhD
Attending Physician, Professor
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
 
Benjamin Levy, MD
Associate Professor
The Johns Hopkins School of Medicine
 
Imad A. Tabbara, MD, FACP
Chief, Division of Hematology/Oncology, DeCesaris Cancer Institute
Clinical Professor of Medicine
The George Washington University
 
Staff
Leticia Hall
Sheena King
Naomi Loughlin
 

Absence of Relevant Financial Relationships

The following planners, faculty, staff, and others in a position to control the content of this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.
 
  • Robert S. Siegel, MD
  • Nilofer Azad, MD
  • Edward Chu, MD
  • Leticia Hall
  • Sheena King
  • Naomi Loughlin
Relevant Financial Relationships
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following individuals in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
 
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
All relevant financial relationships listed for these individual(s) have been mitigated.
 
  • Jeanny B. Aragon-Ching, MD, FACP, a speaker for this accredited CE activity, is on the advisory board of Algeta/Bayer, Astra Zeneca, Pfizer, Dendreon, EMD Serono, Janssen/Ortho-Biotech Merck , and Sanofi.
  • Pavani Chalasani, MD, a speaker for this accredited CE activity, is an advisor for Astrazeneca, Eisai, Gilead, Novartis, and Pfizer.
  • Benjamin Levy, MD, a speaker for this accredited CE activity, is an advisor/consultant for AstraZeneca, Daiichi Sankyo, Eli Lilly, Genentech, Janssen, Merck, Mirati, Novartis, and Pfizer.
  • Matthias Holdhoff, MD, PhD, a speaker for this accredited CE activity, is on the Board of Advarra and Parexel.
  • David H. Ilson, MD PhD, a speaker for this accredited CE activity, is a consultant for Astellas, Bristol Myers Squibb, Merck, and Roche.
  • Imad Tabbara, a speaker for this accredited CE activity, is on the speaker’s bureau for Abbvie, Beigene, Takeda, BMS, GSK, Pharmacyclics, and Sanofi/Morphosys.
Disclaimer
The information in this accredited CE activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this accredited CE activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.
 
Acknowledgement of Commercial Support
This accredited CE activity did not receive any commercial support.

Accreditation

Accreditation Statements
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Credit Designation Statement(s)
Physicians (CME)
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Physician ABIM Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for this activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Other Healthcare Professionals (Attendance)
All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance.  Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.

 

Available Credit

  • 7.00 ABIM MOC 2
  • 7.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 7.00 Completion

Exhibitors

Exhibits & Sponsorships

Secure your spot at the 2023 Oncology Update Symposium!

There will be exhibit breaks dedicated for attendees to visit the exhibit hall to learn about the latest technology, services, and devices and to connect one-on-one with exhibitors and sponsors.

Exhibits and sponsorship opportunities are available on a first-come, first serve basis. Find out more information by downloading the PDF icon 2023 Oncology Update Symposium Exhibitor Prospectus Application.pdf

SPONSORSHIP

The Hematology Update is a great opportunity for your company to display your products and services and to interact with our audience of 150+ physicians, nurses and allied healthcare professionals.

Why Exhibit

Our Sponsor Exhibitors will have the opportunity to:

  • Demonstrate your company’s commitment to improving the care of patients with cancerous tumors
  • Educate physicians and other healthcare professionals about your company’s products and service
  • Benefit from extended Exhibit Hours throughout the day, giving you maximum visibility
  • Reach decision makers in the Oncology market
  • Increase your Team and Company’s visibility

HEMONCBP EXHIBIT HALL

Our HEMONCBP Exhibit Hall will offer our Exhibitors the following benefits:

  • Maximum visibility and exposure to your target market
  • Complimentary Educational Sessions & Exhibit Hall Access for (2) two Company Personnel
  • Acknowledgment in Online Course Materials (subject to set course material deadlines)
  • Acknowledgement in Educational Sessions

Sponsor Exhibitor Registration Fees

Please refer to the “Registration and Fees” tab for Industry rates.

Sponsor Exhibitor Schedule

Please Note: Refer to the program tab for agenda details. 

Exhibitor Prospectus

If you are interested in exhibiting at our HEMONCBP Exhibit Hall during our live sessions, please download the PDF icon 2023 Oncology Update Symposium Exhibitor Prospectus Application.pdf for more information or you can register through the online exhibitor registration link. 2023 Oncology Update Exhibitor Sponsorship Application

 

Register/Take course

Price

Cost:
$100.00
Please login or register to take this course.

REGISTRATION FEES

When you register for the Oncology Update Symposium, the registration fee includes:

  • Access to the Educational Sessions and Q&A Sessions
  • Access to Product Forum Sessions sponsored by Life Science Industry representatives
  • Access to the HEMONCBP Exhibit Hall and connect with our Sponsor Exhibitors
  • Access Online to the Course Materials (course electronic syllabus and PDF slide handouts)
  • Access to Archived Session Recordings until Monday, December 31, 2024
  • CME Credit and MOC Points

live | in person registration fees

  • Registration fees includes Continental Breakfast, Refreshments and Lunch

PARTICIPANT TYPE

REGISTRATION FEE

 

Please register by
Friday, June 23rd.

Physicians

$100.00

Residents | Fellows

$25.00

Nurses | Pharmacists | APN | APA | Advanced Practice Providers | Allied Professionals and Other Healthcare Providers

$50.00

Industry

$125.00

 

Sponsored Lunch product forum registration

Lunch Product Forum Hosted by Genmab:
Unveiling a New Therapy in 3L+ DLBCL- Discussing the first-and-only subcutaneous bispecific antibody in 3L+ DLBCL

Presenter: Alan Skarbnik, MD
                    System Director, Lymphoma and CLL Program | System Director, Immune Effector Cell 
                    and Experimental Therapeutics Program Novant Health Cancer Institute
                    Clinical Assistant Professor, University of North Carolina School of Medicine

Time: 12:15 PM – 1:15 PM | Location: Engage Room

We ask attendees to pre-register by clicking this pre-registration link:  GENMAB LUNCH PRODUCT FORUM PRE-REGISTRATION LINK


PURCHASE DISCLAIMER

  • Please note that the Ethos CE system is designed to track individual learning. The learning system does not permit shared login; any attempt of this activity will be monitored and your subscription will be at risk to be suspended at GW's discretion.

ATTENDEE INQUIRIES | FREQUENTLY ASKED QUESTIONS

  • Please contact the FINA Conference Logistics Team at HEMONCBP_Inquiries@finaww.com, if you have any questions or you can refer to the FAQ document.